These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 23319292)

  • 1. Development of a new method for assessing global risk of Alzheimer's disease for use in population health approaches to prevention.
    Anstey KJ; Cherbuin N; Herath PM
    Prev Sci; 2013 Aug; 14(4):411-21. PubMed ID: 23319292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data.
    Norton S; Matthews FE; Barnes DE; Yaffe K; Brayne C
    Lancet Neurol; 2014 Aug; 13(8):788-94. PubMed ID: 25030513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The projected effect of risk factor reduction on Alzheimer's disease prevalence.
    Barnes DE; Yaffe K
    Lancet Neurol; 2011 Sep; 10(9):819-28. PubMed ID: 21775213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 12-week multidomain intervention versus active control to reduce risk of Alzheimer's disease: study protocol for a randomized controlled trial.
    Anstey KJ; Bahar-Fuchs A; Herath P; Rebok GW; Cherbuin N
    Trials; 2013 Feb; 14():60. PubMed ID: 23442574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of modifiable risk factors for Alzheimer's disease.
    Xu W; Tan L; Wang HF; Jiang T; Tan MS; Tan L; Zhao QF; Li JQ; Wang J; Yu JT
    J Neurol Neurosurg Psychiatry; 2015 Dec; 86(12):1299-306. PubMed ID: 26294005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk and protective factors for sporadic Alzheimer's disease.
    Stozická Z; Zilka N; Novák M
    Acta Virol; 2007; 51(4):205-22. PubMed ID: 18197729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.
    Antwi F; Fazylova N; Garcon MC; Lopez L; Rubiano R; Slyer JT
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-14. PubMed ID: 27820152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing Alzheimer's disease and cognitive decline.
    Williams JW; Plassman BL; Burke J; Benjamin S
    Evid Rep Technol Assess (Full Rep); 2010 Apr; (193):1-727. PubMed ID: 21500874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of Alzheimer's disease: a global challenge for next generation neuroscientists.
    Rodríguez-Gómez O; Palacio-Lacambra ME; Palasí A; Ruiz-Laza A; Boada-Rovira M
    J Alzheimers Dis; 2014; 42 Suppl 4():S515-23. PubMed ID: 25351111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the CogDrisk tool to assess risk factors for dementia.
    Anstey KJ; Kootar S; Huque MH; Eramudugolla R; Peters R
    Alzheimers Dement (Amst); 2022; 14(1):e12336. PubMed ID: 35845259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female specific risk factors for the development of Alzheimer's disease neuropathology and cognitive impairment: Call for a precision medicine approach.
    Udeh-Momoh C; Watermeyer T;
    Ageing Res Rev; 2021 Nov; 71():101459. PubMed ID: 34508876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology of Alzheimer's disease].
    Dufouil C; Alpérovitch A
    Rev Prat; 2005 Nov; 55(17):1869-78. PubMed ID: 16396227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical activity, diet, and risk of Alzheimer disease.
    Scarmeas N; Luchsinger JA; Schupf N; Brickman AM; Cosentino S; Tang MX; Stern Y
    JAMA; 2009 Aug; 302(6):627-37. PubMed ID: 19671904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gout and the risk of Alzheimer's disease: a population-based, BMI-matched cohort study.
    Lu N; Dubreuil M; Zhang Y; Neogi T; Rai SK; Ascherio A; Hernán MA; Choi HK
    Ann Rheum Dis; 2016 Mar; 75(3):547-51. PubMed ID: 25739830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
    Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
    Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial association of angiotensin-converting enzyme inhibitors and statins on the occurrence of possible Alzheimer's disease after traumatic brain injury.
    Li M; Reisman J; Morris-Eppolito B; Qian SX; Kazis LE; Wolozin B; Goldstein LE; Xia W
    Alzheimers Res Ther; 2020 Mar; 12(1):33. PubMed ID: 32220235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Alzheimer's Disease Risk Modifiable?
    Serrano-Pozo A; Growdon JH
    J Alzheimers Dis; 2019; 67(3):795-819. PubMed ID: 30776012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of Alzheimer's disease: population-based estimates and projections for New Zealand, 2006-2031.
    Tobias M; Yeh LC; Johnson E
    Aust N Z J Psychiatry; 2008 Sep; 42(9):828-36. PubMed ID: 18696288
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.